These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30366983)

  • 1. Loss of cyclin-dependent kinase 1 impairs bone formation, but does not affect the bone-anabolic effects of parathyroid hormone.
    Takahashi A; Mulati M; Saito M; Numata H; Kobayashi Y; Ochi H; Sato S; Kaldis P; Okawa A; Inose H
    J Biol Chem; 2018 Dec; 293(50):19387-19399. PubMed ID: 30366983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Osteoblast to Osteocyte Differentiation by Cyclin-Dependent Kinase-1.
    Tanaka T; Miyakoshi Y; Kobayashi Y; Xiaolong S; Daiyang Y; Ochi H; Sato S; Kato T; Yoshii T; Okawa A; Kaldis P; Inose H
    Adv Biol (Weinh); 2023 Dec; 7(12):e2300136. PubMed ID: 37424388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between p21-activated kinase 4 and β-catenin as a novel pathway for PTH-dependent osteoblast activation.
    Shen C; Oh HR; Park YR; Chen JH; Park BH; Park JH
    J Cell Physiol; 2024 Jun; 239(6):e31245. PubMed ID: 38497504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
    Zhang K; Wang M; Li Y; Li C; Tang S; Qu X; Feng N; Wu Y
    Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E590-E604. PubMed ID: 30668150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
    Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
    J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gprc5a is a novel parathyroid hormone-inducible gene and negatively regulates osteoblast proliferation and differentiation.
    Sampei C; Kato K; Arasaki Y; Kimura Y; Konno T; Otsuka K; Kohara Y; Noda M; Ezura Y; Hayata T
    J Cell Physiol; 2024 Aug; 239(8):e31297. PubMed ID: 38769895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43.
    Chung DJ; Castro CH; Watkins M; Stains JP; Chung MY; Szejnfeld VL; Willecke K; Theis M; Civitelli R
    J Cell Sci; 2006 Oct; 119(Pt 20):4187-98. PubMed ID: 16984976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose dependent miR-451a expression contributes to parathyroid hormone mediated osteoblast differentiation.
    Karvande A; Kushwaha P; Ahmad N; Adhikary S; Kothari P; Tripathi AK; Khedgikar V; Trivedi R
    Bone; 2018 Dec; 117():98-115. PubMed ID: 30218791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Indispensable Role of Cyclin-Dependent Kinase 1 in Skeletal Development.
    Saito M; Mulati M; Talib SZ; Kaldis P; Takeda S; Okawa A; Inose H
    Sci Rep; 2016 Feb; 6():20622. PubMed ID: 26860366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
    Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
    J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone induces mitogen-activated kinase phosphatase 1 in murine osteoblasts primarily through cAMP-protein kinase A signaling.
    Aghaloo TL; Pirih FQ; Shi A; Bezouglaia O; Tetradis S
    J Periodontol; 2006 Jan; 77(1):21-30. PubMed ID: 16579699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
    Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
    Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone.
    Saito H; Gasser A; Bolamperti S; Maeda M; Matthies L; Jähn K; Long CL; Schlüter H; Kwiatkowski M; Saini V; Pajevic PD; Bellido T; van Wijnen AJ; Mohammad KS; Guise TA; Taipaleenmäki H; Hesse E
    Nat Commun; 2019 Mar; 10(1):1354. PubMed ID: 30902975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
    Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
    Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.